drugset / Trial / NCT01416376
Effect of Multiple Dose Levels of SRT2379 on Endotoxin-Induced Inflammation
RandomizedParallel-groupDouble-blindBasic science
Summary
SRT2379 is a potent small molecule activator of SIRT1 that has been found to inhibit systemic inflammation induced by intravenous injection of lipopolysaccharide (LPS) in mice. The objective of this study is to determine the effect of a single administration of SRT2379, at multiple-dose levels, on the inflammatory response to low dose endotoxin.
Timeline
- Start
- 2011-08-30
- Primary completion
- 2011-12-12
- Completion
- 2011-12-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | SRT2379 | Small molecule | 50 mg | Oral |
| Comparator | SRT2379 | Small molecule | 250 mg | Oral |
| Comparator | SRT2379 | Small molecule | 1000 mg | Oral |